false
Catalog
Dual Diagnoses of Youth Substance Use Disorders an ...
Recording Presentation
Recording Presentation
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The video is a webinar on dual diagnosis of substance use disorders and depression. It is presented by Dr. Amy Ewell on behalf of the American Psychiatric Association. The webinar is part of the SAMHSA-funded Provider Clinical Support System, a program operated by 19 medical specialty organizations. Dr. Ewell acknowledges that a follow-up email will be sent after the presentation, containing instructions on how to claim credit for attending. She introduces Dr. Yifrah Kammer, who is a child and adolescent psychiatrist and a professor emeritus of psychiatry and pediatrics at the University of Connecticut Medical School. Dr. Kammer discusses the nature of the association between substance use disorders and depression, as well as treatment implications. He talks about the different co-occurring models for dual diagnosis and the importance of understanding the factors that contribute to the development of co-occurring disorders. Dr. Kammer also discusses the impact of co-occurring disorders on individuals and emphasizes the need for integrated treatment approaches. He presents findings from studies on the treatment of co-occurring disorders, including cognitive-behavioral therapy and motivational interviewing. Dr. Kammer also discusses the use of adaptive treatment design and the importance of addressing co-occurring disorders in adolescents. The video ends with a Q&A session and a discussion on resources and barriers to treatment.
Keywords
dual diagnosis
substance use disorders
depression
webinar
Dr. Amy Ewell
American Psychiatric Association
SAMHSA-funded Provider Clinical Support System
co-occurring disorders
integrated treatment approaches
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.
Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 and grant no. 1H79TI085588 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
PCSS-MOUD
PCSS-MOUD.org
pcss@aaap.org
8-Hour DEA Training Inquiries, email
PCSS-MOUD
.
ORN
opioidresponsenetwork.org
×
Please select your language
1
English